Cargando…

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study

OBJECTIVE: Schizophrenia and/or antipsychotic drug use are associated with metabolic abnormalities; however, knowledge regarding metabolic status and physician’s monitoring of metabolic status at first schizophrenia diagnosis is sparse. We assessed the prevalence of monitoring for metabolic blood ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horsdal, Henriette Thisted, Benros, Michael Eriksen, Köhler-Forsberg, Ole, Krogh, Jesper, Gasse, Christiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338955/ https://www.ncbi.nlm.nih.gov/pubmed/28280344 http://dx.doi.org/10.2147/NDT.S119632

Ejemplares similares

Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia
por: Köhler, Ole, et al.
Publicado: (2016)

Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2018)

Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2019)

Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022)

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
por: Köhler, Ole, et al.
Publicado: (2016)

T11. CEREBROSPINAL FLUID (CSF) MARKERS OF INFLAMMATION AND INFECTIONS IN SCHIZOPHRENIA AND AFFECTIVE DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Orlovska, Sonja, et al.
Publicado: (2018)

F137. INFECTIONS OF THE CENTRAL NERVOUS SYSTEM AS A RISK FACTOR FOR MENTAL DISORDERS AND COGNITIVE IMPAIRMENT: A NATIONWIDE REGISTER-BASED STUDY
por: Pedersen, Emilie, et al.
Publicado: (2018)

Lack of fit with the neighbourhood social environment as a risk factor for psychosis – a national cohort study
por: Schofield, Peter, et al.
Publicado: (2023)

A comparison of neighbourhood level variation and risk factors for affective versus non-affective psychosis
por: Schofield, Peter, et al.
Publicado: (2023)

Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes
por: Köhler, Ole, et al.
Publicado: (2015)

The Role of Infections and Autoimmune Diseases for Schizophrenia and Depression: Findings from Large-Scale Epidemiological Studies
por: Benrós, Michael Eriksen, et al.
Publicado: (2015)

Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies
por: Futtrup, Jesper, et al.
Publicado: (2020)

Association of Childhood Exposure to Nitrogen Dioxide and Polygenic Risk Score for Schizophrenia With the Risk of Developing Schizophrenia
por: Horsdal, Henriette Thisted, et al.
Publicado: (2019)

Parental income as a marker for socioeconomic position during childhood and later risk of developing a secondary care-diagnosed mental disorder examined across the full diagnostic spectrum: a national cohort study
por: Hakulinen, Christian, et al.
Publicado: (2020)

Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
por: Köhler-Forsberg, Ole, et al.
Publicado: (2020)

Higher depression risks in medium- than in high-density urban form across Denmark
por: Chen, Tzu-Hsin Karen, et al.
Publicado: (2023)

Chronic Somatic Comorbidity and Excess Mortality Due to Natural Causes in Persons with Schizophrenia or Bipolar Affective Disorder
por: Laursen, Thomas Munk, et al.
Publicado: (2011)

T214. ANTIPSYCHOTIC TREATMENT PATTERNS AND EFFECTS DURING THE EARLY YEARS AMONG 316 NEWLY DIAGNOSED PATIENTS WITH SCHIZOPHRENIA FROM THE OPUS TRIAL
por: Albert, Nikolai, et al.
Publicado: (2020)

The Risk of Schizophrenia and Child Psychiatric Disorders in Offspring of Mothers with Lung Cancer and Other Types of Cancer: A Danish Nationwide Register Study
por: Benros, Michael Eriksen, et al.
Publicado: (2013)

Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
por: Gasse, Angela, et al.
Publicado: (2020)

Autoimmune Diseases and Psychotic Disorders
por: Jeppesen, Rose, et al.
Publicado: (2019)

COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
por: Vindegaard, Nina, et al.
Publicado: (2020)

Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders
por: Orbe, Elif Bayram, et al.
Publicado: (2023)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

Differential effects of specific antipsychotic drugs on metabolic markers and diabetes: A register-based study on 4,909 patients with schizophrenia
por: Sørensen, M. A., et al.
Publicado: (2023)

Editorial: The metabolic effect of prolactin
por: Krogh, Jesper
Publicado: (2023)

Deep learning–based integration of genetics with registry data for stratification of schizophrenia and depression
por: Allesøe, Rosa Lundbye, et al.
Publicado: (2022)

T83. SUBSTANCE-INDUCED PSYCHOSIS LINKED TO BOTH INFECTIONS AND SCHIZOPHRENIA
por: Hjorthøj, Carsten, et al.
Publicado: (2020)

Associations between patterns in comorbid diagnostic trajectories of individuals with schizophrenia and etiological factors
por: Krebs, Morten Dybdahl, et al.
Publicado: (2021)

Declining Use of Potentially Inappropriate Medication in People with Dementia from 2000 to 2015: A Repeated Cross-Sectional Nationwide Register-Based Study
por: Kristensen, Rachel Underlien, et al.
Publicado: (2021)

Can Exercise Increase Fitness and Reduce Weight in Patients with Schizophrenia and Depression?
por: Krogh, Jesper, et al.
Publicado: (2014)

Microservices in .NET Core: with examples in Nancy
por: Gammelgaard, Christian Horsdal
Publicado: (2017)

Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: A Population Based Cohort Study
por: Sun, Yuelian, et al.
Publicado: (2015)

Correction: Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: a Population Based Cohort Study
por: Sun, Yuelian, et al.
Publicado: (2016)

Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
por: Oviedo-Salcedo, Tatiana, et al.
Publicado: (2021)

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
por: Sass, Marie Reeberg, et al.
Publicado: (2023)

Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis
por: Byberg, Sarah, et al.
Publicado: (2019)

Need for improved diabetes support among people with psychiatric disorders and diabetes treated in psychiatric outpatient clinics: results from a Danish cross-sectional study
por: Knudsen, Lenette, et al.
Publicado: (2022)

Prodromal phase and first episode psychosis in schizophrenia: early signs and diagnosis
por: Buciuc, A.-G., et al.
Publicado: (2022)

The risk of developing diabetes during antipsychotic drug treatment: A nationwide study among 31,856 patients with schizophrenia
por: Marker Madsen, N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_86vvsfgpdiv3d9o49kbl98ft07